We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPHS
7476
DELISTED
Sophiris Bio, Inc.
SPHS
$49K ﹤0.01%
21,608
-15,113
-41% -$32.9K
SXE
7477
DELISTED
Southcross Energy Partners, L.P.
SXE
$49K ﹤0.01%
+29,265
New +$55K
ALTO icon
7478
PUT
Alto Ingredients
ALTO
$369M
$48K ﹤0.01%
10,600
-27,200
-72% -$129K
SACH
7479
Sachem Capital Corp
SACH
$39.1M
$48K ﹤0.01%
+12,292
New +$50.8K
SRNE
7480
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$48K ﹤0.01%
12,586
-20,137
-62% -$52.4K
BBOX
7481
PUT
DELISTED
Black Box Corp
BBOX
$48K ﹤0.01%
13,600
+1,700
+14% +$5.6K
NEPT
7482
PUT
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$47K ﹤0.01%
+14
New +$25.4K
JRJC
7483
CALL
DELISTED
China Finance Online Co., Ltd.
JRJC
$47K ﹤0.01%
1,760
+390
+28% +$8.84K
ANW
7484
CALL
DELISTED
Aegean Marine Petroleum Network
ANW
$47K ﹤0.01%
11,000
-1,800
-14% -$7.6K
ASM
7485
Avino Silver & Gold Mines
ASM
$934M
$46K ﹤0.01%
34,671
+14,862
+75% +$20.2K
DHX icon
7486
DHI Group
DHX
$182M
$46K ﹤0.01%
+23,766
New +$49.3K
EXK
7487
CALL
Endeavour Silver
EXK
$2.23B
$46K ﹤0.01%
+19,100
New +$43.1K
ASXC
7488
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
$46K ﹤0.01%
1,831
-4,269
-70% -$131K
ARAV
7489
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
$46K ﹤0.01%
3,450
-9,150
-73% -$118K
HSTO
7490
PUT
DELISTED
Histogen Inc. Common Stock
HSTO
$46K ﹤0.01%
+50
New +$46.2K
SAEX
7491
DELISTED
SAExploration Holdings, Inc.
SAEX
$46K ﹤0.01%
+1,046
New +$40.8K
ARQL
7492
DELISTED
Arqule Inc
ARQL
$46K ﹤0.01%
27,985
+15,094
+117% +$19.6K
WAC
7493
DELISTED
Walter Investment Mgt Corp
WAC
$46K ﹤0.01%
+54,929
New +$29.5K
EFOI icon
7494
Energy Focus
EFOI
$19.4M
$45K ﹤0.01%
+531
New +$48.4K
INOD icon
7495
Innodata
INOD
$2.05B
$45K ﹤0.01%
+33,110
New +$39.7K
MYO icon
7496
Myomo
MYO
$39M
$45K ﹤0.01%
396
-186
-32% -$22.2K
UTI icon
7497
Universal Technical Institute
UTI
$2.16B
$45K ﹤0.01%
+18,573
New +$58.4K
ATYR
7498
aTyr Pharma
ATYR
$47.6M
$45K ﹤0.01%
+917
New +$56.4K
ASNA
7499
DELISTED
Ascena Retail Group, Inc.
ASNA
$45K ﹤0.01%
965
-6,428
-87% -$271K
BXE
7500
DELISTED
Bellatrix Exploration Ltd.
BXE
$45K ﹤0.01%
+26,043
New +$55.9K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.